1.
Hinyokika Kiyo
; 51(2): 113-6, 2005 Feb.
Article
in Japanese
| MEDLINE
| ID: mdl-15773365
ABSTRACT
We report two cases of metastatic urothelial cancer treated with high-dose-intensity (HD) methotrexate vinblastine, doxorubicin and cisplatin (MVAC). After HD-MVAC, the size of primary and lymph node tumors decreased by 57-67% as compared with the standard M-VAC therapy. By shortening the dose interval, HD-MVAC may increase the anti-tumor effect without increasing side effects.